chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 17.0
Sex: F
Vaccine: HPV4
Symptoms: Convulsion
Clinical narrative: Information has been received from a registered nurse concerning a 19 year old female who on 04-APR-2007 was vaccinated with first dose of GARDASIL (route not reported, lot number 655324/0088U). The registered nurse reported that the patient experienced seizure-like activity that occurred a few days after the first dose was given to the patient. It was reported that the patient received the second dose of GARDASIL (route not reported, lot number 655324/ 65863/1063U). It was unspecified if the patient had the same symptoms after she received the second dose because the registered nurse had not heard from the patient since her check-up on 08-APR-2007. The registered nurse reported that therapy with GARDASIL was discontinued on 26-OCT-2007. The patient sought medical attention by contacting the nurse. Upon internal review, seizure like activity was determined to be an other important medical event. Additional information has been requested.
Age: 45.0
Sex: F
Vaccine: TYP
Symptoms: Oedema peripheral, Pain, Urticaria
Clinical narrative: Post 1st Dose 07.15.09 Throbbing behind ear.  Post second dose 07.17.09 Hives all over body swollen hands & feet.
Age: 0.2
Sex: F
Vaccine: DTAPIPVHIB, PNC
Symptoms: Crying, Feeding disorder, Insomnia
Clinical narrative: "Cried for 3 d"; cried for more than 3 hrs straight without sleep or feedings per mom's report.
Age: 36.0
Sex: F
Vaccine: HEPAB
Symptoms: Urticaria
Clinical narrative: Hives on thighs BENADRYL and Aloe Vera
Age: 1.3
Sex: M
Vaccine: MMR, VARCEL
Symptoms: Speech disorder
Clinical narrative: Information has been received from a registered nurse concerning a now 24 months old male who in October 2008, at the age of "15 months old" was vaccinated with MMR II and VARIVAX. Apparently within 24 hours of receiving both vaccinations, the patient developed a decreasing ability to speak. Unspecified medical attention was sought. At the time of the report, the patient had not improved. The decreasing ability to speak was considered to be disabling. Additional information has been requested.
Age: 13.0
Sex: U
Vaccine: MMR
Symptoms: Autism
Clinical narrative: Information has been received from a registered nurse concerning a 13 year old patient who was believed to be vaccinated with MMR II and was believed to be autistic. Upon internal review, autism was determined to be other important medical event. Additional information has been requested.
Age: 50.0
Sex: F
Vaccine: TTOX
Symptoms: Blood test, Burning sensation, Erythema, Myalgia, Oedema mouth
Clinical narrative: Initial report was received 20 July 2009 from a consumer in the country, who is also the patient. A 50-year-old female patient with a history of a stray cat bite, had received a left deltoid injection of Tetanus Toxoid (manufacturer, lot number and route not reported) at 15:00 hours on 11 July 2009 for wound management, and at approximately 18:30 hours, she became itchy on her abdomen and under her breast area. She also developed hives, and her face, mouth and hands turned red with a burning and stinging sensation. Her mouth and throat felt swollen and her throat felt like it was locked. The patient was prescribed a Z-PACK antibiotic on the day of the event, which she started taking an unspecified amount of time prior to the event onset. The patient was treated by emergency services and was taken to the hospital at which time she received BENADRYL and steroids. The patient was kept for observation and then discharged. The patient was instructed to continue taking oral BENADRYL and was prescribed a MEDROL PACK which she never had filled. Her diagnosis had been possible acute allergic reaction. The following day, on 12 July 2009, she was seen at a walk-in clinic due to persistent symptoms; no additional treatments were prescribed. On 13 July 2009, she went to the hospital with the same symptoms and left sided muscle pain that extended from her shoulder to her throat. She was given TORADOL and morphine for pain and kept for observation until 14 July 2009. The patient's last tetanus vaccination had been 10 -12 years ago. Per the reporter, she could not remember having this kind of a reaction after receiving a tetanus vaccine in the past. The patient had a past history of seasonal allergies, asthma, sinus problems, cardiac arrythmias and allergies to dust, latex, nickel, penicillin. She had been taking ZYRTEC, TOPROL XL, Albuterol inhaler and CARDIZEM concomitantly. At the time of the report, her recovery status was reported as unknown. Documents held by sender: None
Age: 50.0
Sex: F
Vaccine: TTOX
Symptoms: Pain, Pharyngeal oedema, Pruritus, Throat tightness, Urticaria
Clinical narrative: Initial report was received 20 July 2009 from a consumer in the country, who is also the patient. A 50-year-old female patient with a history of a stray cat bite, had received a left deltoid injection of Tetanus Toxoid (manufacturer, lot number and route not reported) at 15:00 hours on 11 July 2009 for wound management, and at approximately 18:30 hours, she became itchy on her abdomen and under her breast area. She also developed hives, and her face, mouth and hands turned red with a burning and stinging sensation. Her mouth and throat felt swollen and her throat felt like it was locked. The patient was prescribed a Z-PACK antibiotic on the day of the event, which she started taking an unspecified amount of time prior to the event onset. The patient was treated by emergency services and was taken to the hospital at which time she received BENADRYL and steroids. The patient was kept for observation and then discharged. The patient was instructed to continue taking oral BENADRYL and was prescribed a MEDROL PACK which she never had filled. Her diagnosis had been possible acute allergic reaction. The following day, on 12 July 2009, she was seen at a walk-in clinic due to persistent symptoms; no additional treatments were prescribed. On 13 July 2009, she went to the hospital with the same symptoms and left sided muscle pain that extended from her shoulder to her throat. She was given TORADOL and morphine for pain and kept for observation until 14 July 2009. The patient's last tetanus vaccination had been 10 -12 years ago. Per the reporter, she could not remember having this kind of a reaction after receiving a tetanus vaccine in the past. The patient had a past history of seasonal allergies, asthma, sinus problems, cardiac arrythmias and allergies to dust, latex, nickel, penicillin. She had been taking ZYRTEC, TOPROL XL, Albuterol inhaler and CARDIZEM concomitantly. At the time of the report, her recovery status was reported as unknown. Documents held by sender: None
Age: 22.0
Sex: F
Vaccine: HPV4
Symptoms: Cognitive disorder, Dyskinesia, Hyperhidrosis, No reaction on previous exposure to drug, Presyncope
Clinical narrative: Information has been received from a nurse concerning a 22 year old female patient with penicillin allergy who on 07-JAN-2009 was vaccinated with the first dose of GARDASIL (lot number not reported). The patient received the second dose on 12-MAR-2009 (lot number not reported) and the third 00.5 ml dose on 13-JUL-2009 (lot number 661044/0548X). Concomitant therapy included YAZ. Subsequently, the patient experienced shaking, sweating and quivering. The patient also had jerk movement with her legs and her hands, and she was not cognitive for about 20 seconds after she received the third dose of GARDASIL. Later, the patient was given food and water, and right after that the patient had vomiting. It was unspecified if lab studies were performed. The patient stabilized after 45 minutes. It was reported that the patient had an empty stomach at the time of vaccination. The nurse also reported that the patient did not experience any adverse events after the first and second dose. Follow-up information received from the nurse on 20-JUL-2009: The lot number for all three doses is 661044/0548X. There was no concomitant therapy with the third dose. The patient's jerky movements were not tonic-clonic movements. The patient did not lose consciousness. There was no seizure happened. The vaccine was administered after the patient had a gynecology (GYN) exam and she was highly anxious. According to the nurse, the event (probably vasovagal) was considered as disabling for the 45 minutes during which the event occurred. No further information expected.
Age: 22.0
Sex: F
Vaccine: HPV4
Symptoms: Tremor, Vomiting
Clinical narrative: Information has been received from a nurse concerning a 22 year old female patient with penicillin allergy who on 07-JAN-2009 was vaccinated with the first dose of GARDASIL (lot number not reported). The patient received the second dose on 12-MAR-2009 (lot number not reported) and the third 00.5 ml dose on 13-JUL-2009 (lot number 661044/0548X). Concomitant therapy included YAZ. Subsequently, the patient experienced shaking, sweating and quivering. The patient also had jerk movement with her legs and her hands, and she was not cognitive for about 20 seconds after she received the third dose of GARDASIL. Later, the patient was given food and water, and right after that the patient had vomiting. It was unspecified if lab studies were performed. The patient stabilized after 45 minutes. It was reported that the patient had an empty stomach at the time of vaccination. The nurse also reported that the patient did not experience any adverse events after the first and second dose. Follow-up information received from the nurse on 20-JUL-2009: The lot number for all three doses is 661044/0548X. There was no concomitant therapy with the third dose. The patient's jerky movements were not tonic-clonic movements. The patient did not lose consciousness. There was no seizure happened. The vaccine was administered after the patient had a gynecology (GYN) exam and she was highly anxious. According to the nurse, the event (probably vasovagal) was considered as disabling for the 45 minutes during which the event occurred. No further information expected.
Age: 26.0
Sex: F
Vaccine: HPV4
Symptoms: Deep vein thrombosis
Clinical narrative: Information has been received from a physician concerning a 26 year old female with no known allergies or reported medical history who on 07-JAN-2009 was vaccinated with the first and only dose of GARDASIL (lot# 661531/1311X) 0.5 ml, I.M. route. Concomitant therapy included NECON 1/35. On 08-APR-2009, the patient experienced deep vein thrombosis. The patient was treated with anticoagulation therapy including LOVENOX and COUMADIN. Subsequently, the patient was recovered. The physician stated that "clots can be dangerous" and deep vein thrombosis was considered to be immediately life-threatening. Additional information has been requested.   8/10/09 ER Records received DOS 4/9/09. Assessment: Soleal vein thrombosis left mid calf. Patient presents with pain of left calf exacerbated by walking/movement. Stopped taking birth control pills today.  8/17/09 Consultant records received DOS 4/13/09 to 6/04/09. Assessment: Acute DVT left perineal and soleus veins. Patient reported to physican's office with left leg pain and was sent to ER for initiation of therapy for DVT. Placed on anticoagulation. Sent to consultant's office for follow-up. Presents with left calf tenderness. Urinary tract infection. left ear pain, congested, pressure and slight dizziness. Increased anxiety. Fatigue. Tympanic membranes show serous fluid accumulation.
Age: 33.0
Sex: F
Vaccine: HEP, TDAP
Symptoms: Asthenia, Diarrhoea, Fatigue, Nausea
Clinical narrative: Patient states she had fatique, weak and nausiated. Had diarrhea over the weekend following administration.  Patient followed up with PCP 1 week after administration of vaccine.
Age: 3.0
Sex: M
Vaccine: DTAP
Symptoms: Injection site erythema, Injection site nodule, Injection site pain, Injection site swelling
Clinical narrative: Redness, swollen, nodule, tender to touch left thigh injection site of Dtap vaccination on 7/15/09 back in office for reevaluation on 7/17/09 and treatment as follows: reaction to DTAP likely, discussed monitor for fever, pus. motrin/ tylenol if tender, can use ice and mild compression for comfort. call if problems or difficulty. Dad aware and agrees.
Age: 4.0
Sex: F
Vaccine: DTAP, HEPA, IPV, MMR, VARCEL
Symptoms: Injection site erythema, Injection site induration, Injection site pain, Injection site pruritus, Injection site swelling
Clinical narrative: 24 hours after immunization, Left arm red,swollen and is painful and itchy. Left upper arm redness and induration(7cm). Slightly tender. Treatment: cool compresses, analgesics. recheck PRN
Age: 1.44
Sex: U
Vaccine: TD
Symptoms: Conjunctivitis infective, Eyelid margin crusting, Pyrexia
Clinical narrative: UPON PHONE CALL WE MADE TO CHECK PATIENT STATUS ON 10/18/2005 PATIENT MOTHER STATED THAT THE PATIENT WAS DOING FINE, THE CHILD DID HAVE A FEVER OF 101.00 F. BUT NO LOCALIZED REACTION TO INJECTION. WE MADE ANOTHER FOLLOW UP CALL ON 10/20/2005 TO CHECK PATIENT STATUS AND MOTHER STATED CHILD WAS FINE, DOING WELL STILL HAD FEVER OF 101.00 F. AND EYES WERE "PINK AND CRUSTY". DR. INFORMED MOTHER TO MAKE FOLLOW UP APPOINTMENT TO LOOK AT EYES AND EVALUATE THE FEVER. MOTHER MADE APPOINTMENT FOR 10/21/2005 AND THEN CANCELLED APPOINTMENT AND DID NOT COME FOR ANOTHER APPOINTMENT UNTIL 10/09/2007. THE 10/09/2007 APPOINTMENT WAS FOR A WELL CHILD EXAM.
Age: 17.0
Sex: M
Vaccine: HEPA, MNQ
Symptoms: Back pain, Gait disturbance, Hypoaesthesia, Muscular weakness, Paraesthesia
Clinical narrative: Immunized on 7/15/09, on 7/16/09 at 3 a.m. adolescent began to c/o of numbness and tingling along with weakness in both upper extremities elbows to hands and bilateral lower extremities knees to feet, gait per mom was "stumbling", Temperature 99.6. Adolescent also c/o of back tenderness and pain with touch.  Mom administered Motrin. Mom states child had meningitis fall 08 and had been seen by neurologist.  On 7/16/09 neurologist contacted by mom and adolescent seen on 7/17/09.  Per mom, full neurological exam completed on 7/17/09, at that time numbness and tingling, weakness of arms bilaterally was greatly improved but some numbness, tingling and weakness of the lower extremities remained.  Mom stated that neurologist noted some weakness of lower extremities (knees to feet) but no weakness of upper extremities.  No treatment given by neurolgoist.  All s/s subsided within a few days.  As of today, there is no weakness, numbness, tingling, no c/o of pain and gait is steady.  Son continues to be active in sports.
Age: 17.0
Sex: M
Vaccine: HEPA, MNQ
Symptoms: Pyrexia
Clinical narrative: Immunized on 7/15/09, on 7/16/09 at 3 a.m. adolescent began to c/o of numbness and tingling along with weakness in both upper extremities elbows to hands and bilateral lower extremities knees to feet, gait per mom was "stumbling", Temperature 99.6. Adolescent also c/o of back tenderness and pain with touch.  Mom administered Motrin. Mom states child had meningitis fall 08 and had been seen by neurologist.  On 7/16/09 neurologist contacted by mom and adolescent seen on 7/17/09.  Per mom, full neurological exam completed on 7/17/09, at that time numbness and tingling, weakness of arms bilaterally was greatly improved but some numbness, tingling and weakness of the lower extremities remained.  Mom stated that neurologist noted some weakness of lower extremities (knees to feet) but no weakness of upper extremities.  No treatment given by neurolgoist.  All s/s subsided within a few days.  As of today, there is no weakness, numbness, tingling, no c/o of pain and gait is steady.  Son continues to be active in sports.
Age: 12.0
Sex: M
Vaccine: DTPHEP, MEN, TD, VARCEL
Symptoms: Ear discomfort, Hyperhidrosis, Hypotension, Lethargy, Presyncope
Clinical narrative: After the 4th vaccine was given (menangitis), my son almost fainted. His vision became tunnel vision and he said his ears felt plugged...his arms were drenched in sweat and he became very lethargic. A second nurse rushed in and put an amonia patch under his nose to prevent the fainting spell...he was then wheeled to an observation room where is BP was at lowest 102/49. He was given apple juice and the doctor arrived to perform about 5 more BP checks and after about 10 minutes had him slowly stand and walk. He released us as since my son said he was feeling ok and felt no dizziness.
Age: 12.0
Sex: M
Vaccine: DTPHEP, MEN, TD, VARCEL
Symptoms: Tunnel vision
Clinical narrative: After the 4th vaccine was given (menangitis), my son almost fainted. His vision became tunnel vision and he said his ears felt plugged...his arms were drenched in sweat and he became very lethargic. A second nurse rushed in and put an amonia patch under his nose to prevent the fainting spell...he was then wheeled to an observation room where is BP was at lowest 102/49. He was given apple juice and the doctor arrived to perform about 5 more BP checks and after about 10 minutes had him slowly stand and walk. He released us as since my son said he was feeling ok and felt no dizziness.
Age: 14.0
Sex: U
Vaccine: TDAP
Symptoms: Injection site cellulitis, Injection site erythema, Injection site pain, Injection site warmth
Clinical narrative: 3 CM AREA OF ERYTHEMA, WARMTH, AND TENDERNESS AT THE SITE OF VACCINATION.  SYMPTOMS WERE CONSISTENT WITH CELLULITS, AND THE PATIENT RECEIVED A COURSE OF TRIMETHOPRIM/SULFAMETHOXAZOLE.
Age: 4.0
Sex: M
Vaccine: DTAPIPV
Symptoms: Wrong drug administered
Clinical narrative: KINRIX GIVEN TWICE
Age: 61.0
Sex: M
Vaccine: PPV
Symptoms: Arthralgia, Chills, Injection site erythema, Malaise, Nausea
Clinical narrative: Patient presented to the ER the following day with signs of malaise, joint pain, redness at injection site, nausea, vomitting, fever and chills
Age: 61.0
Sex: M
Vaccine: PPV
Symptoms: Pyrexia, Vomiting
Clinical narrative: Patient presented to the ER the following day with signs of malaise, joint pain, redness at injection site, nausea, vomitting, fever and chills
Age: 14.0
Sex: F
Vaccine: VARCEL
Symptoms: Ecchymosis, Erythema, Oedema, Paraesthesia, Swelling
Clinical narrative: The back of the right arm where the Varicella was administered has some edema which is approximately the size of a ping pong ball. The area has some ecchymosis and erythema as well. The area is not hot and there is not any exudate present. Patient complains of a tingling sensation in the right ring and little fingers.  This was noted Saturday after rising.  No problems were noted on Friday following the Varicella Vaccination. No rash, hives or difficulty breathing.
Age: 30.0
Sex: F
Vaccine: HEP, TDAP
Symptoms: Anxiety, Chills, Crying, Electrocardiogram abnormal, Influenza like illness
Clinical narrative: This employee of the hospital received her TDaP (right) and Hep B (left) vaccines on 7/21/09 around 1530. Awoke in the middle of the night with fever, chills, felt achy all over, and could not lift her right arm that was painful to the touch. The next morning she came on to work at 0700 but throughout the morning developed more flu-like symptoms with progressively worsening all over muscle achiness, increased diffuse muscle achiness. At around 1000, she stood up to stretch and experienced vasovagal syncope with transient loss of consciousness, photophobia, possible fever (tylenol was given 30 min prior to episode however) was very tearful with inconsolable crying present, and very anxious. Code called and employee was shipped to Emergency department. Abnormal ECG and WBC of 16.4 was noted at this time. Given IV NS, ativan 0.5mg IV x2 doses, Zofran 4mg IV, toradol 30mg IV, lortab 5/500mg po x2 tabs. Discharged home from ER with valium 5mg po q8h prn and aleve otc.
Age: 30.0
Sex: F
Vaccine: HEP, TDAP
Symptoms: Injected limb mobility decreased, Loss of consciousness, Myalgia, Pain, Pain in extremity
Clinical narrative: This employee of the hospital received her TDaP (right) and Hep B (left) vaccines on 7/21/09 around 1530. Awoke in the middle of the night with fever, chills, felt achy all over, and could not lift her right arm that was painful to the touch. The next morning she came on to work at 0700 but throughout the morning developed more flu-like symptoms with progressively worsening all over muscle achiness, increased diffuse muscle achiness. At around 1000, she stood up to stretch and experienced vasovagal syncope with transient loss of consciousness, photophobia, possible fever (tylenol was given 30 min prior to episode however) was very tearful with inconsolable crying present, and very anxious. Code called and employee was shipped to Emergency department. Abnormal ECG and WBC of 16.4 was noted at this time. Given IV NS, ativan 0.5mg IV x2 doses, Zofran 4mg IV, toradol 30mg IV, lortab 5/500mg po x2 tabs. Discharged home from ER with valium 5mg po q8h prn and aleve otc.
Age: 30.0
Sex: F
Vaccine: HEP, TDAP
Symptoms: Photophobia, Presyncope, Syncope, White blood cell count abnormal
Clinical narrative: This employee of the hospital received her TDaP (right) and Hep B (left) vaccines on 7/21/09 around 1530. Awoke in the middle of the night with fever, chills, felt achy all over, and could not lift her right arm that was painful to the touch. The next morning she came on to work at 0700 but throughout the morning developed more flu-like symptoms with progressively worsening all over muscle achiness, increased diffuse muscle achiness. At around 1000, she stood up to stretch and experienced vasovagal syncope with transient loss of consciousness, photophobia, possible fever (tylenol was given 30 min prior to episode however) was very tearful with inconsolable crying present, and very anxious. Code called and employee was shipped to Emergency department. Abnormal ECG and WBC of 16.4 was noted at this time. Given IV NS, ativan 0.5mg IV x2 doses, Zofran 4mg IV, toradol 30mg IV, lortab 5/500mg po x2 tabs. Discharged home from ER with valium 5mg po q8h prn and aleve otc.
Age: 1.08
Sex: M
Vaccine: HEPA, MMR, VARCEL
Symptoms: Lymphadenopathy
Clinical narrative: Parent noted swollen lymph nodes in groin and neck.
Age: 52.0
Sex: F
Vaccine: DTAP
Symptoms: Injection site erythema, Injection site induration, Injection site mass
Clinical narrative: 3 inch by 3 inch indurated area with nodularity under the injection site approximately 3 cm by 3 cm. Very TTP, with Rubor
Age: 10.0
Sex: F
Vaccine: VARCEL
Symptoms: Cellulitis, Injection site erythema
Clinical narrative: 7/25/09 patient came in with 4 x 5 inch area of erythema surrounding injection site.  On 7/26/09 patient returned 5 x 5 inch, dr. diagnosed cellulitis
Age: 44.0
Sex: F
Vaccine: DTAP
Symptoms: Oedema peripheral
Clinical narrative: approximately 30 minutes after Tdap immunization employee reported by phone that both hands were swelling by base of thumbs. No airway involvement or rash or other locations of swelling. Advised to report back to ER by husband or by EMS.Employee did not report to ER because symptoms resolved.
Age: 67.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site induration, Injection site pruritus, Injection site swelling, Injection site urticaria, Injection site warmth
Clinical narrative: 24 hours after injection developed a welp.  Within 48 hours arm swelled up to size of "grapefruit" per patient.  See at UTC 72 hours after and given medrol dose pack.  Seen back at on 7/27/09 in our clinic.  Site is slightly warm, hard area under skin ~9 X 5 cm and itchy.  Taking benadryl also.
Age: 1.0
Sex: M
Vaccine: VARCEL
Symptoms: Rash generalised
Clinical narrative: RASH ALL OVER BODY
Age: 62.0
Sex: F
Vaccine: VARZOS
Symptoms: Herpes zoster
Clinical narrative: Received the Shingles vaccination on May 26, 2009.  Onset of Shingles on July 6, 2009. It was strongly recommended that I take the shot, so I finally did.  I questioned two Doctors and one pharmacist as to whether I was a candidate for the vaccination and they all said definitely "yes"?  And all recommeded I take the shot since I have RA and my immune system is compromised.  My husband and I went to the facility---no one questioned me as to my present medications.  After the vaccine was administered, we were given informational sheets which I read when we returned home....Much to my concern, I read that anyone on prednisone now or previously should not get the immunization.....I was on prednisone.  Too late for me...Am taking Valtrex--500 mg/3 daily.
Age: 62.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site pruritus, Injection site warmth
Clinical narrative: Large red, hot and itchy patch or 4" to 5" diameter at the injection site
Age: 18.0
Sex: F
Vaccine: HPV4
Symptoms: Dyspnoea, Haemoglobin normal, Paraesthesia oral, Tuberculin test, Urine analysis
Clinical narrative: Patient experienced problems breathing deeply, had definite wheezing per her mother and then lips started to tingle. Mother said the event probably only lasted 10 minutes from start to finish with only 2 minutes intensity.  This incident occurred about 35 - 40 minutes after administration of her first injection of Gardasil vaccine.  She and her mother sat on an outside bench at a college campus during the intense 1 1/2 -2 minutes until the event was over.
Age: 18.0
Sex: F
Vaccine: HPV4
Symptoms: Wheezing
Clinical narrative: Patient experienced problems breathing deeply, had definite wheezing per her mother and then lips started to tingle. Mother said the event probably only lasted 10 minutes from start to finish with only 2 minutes intensity.  This incident occurred about 35 - 40 minutes after administration of her first injection of Gardasil vaccine.  She and her mother sat on an outside bench at a college campus during the intense 1 1/2 -2 minutes until the event was over.
Age: 15.0
Sex: F
Vaccine: HEPA, HPV4, TDAP
Symptoms: Dizziness, Fall, Pallor, Syncope, Tinnitus
Clinical narrative: Had a syncopal episode in the parking lot.  Received HPV, Hep A and TDAP.  Told mom that she had ringing in the ears and felt dizzy leaving the office.  When she reached the parking lot she was falling down and dizzy and started to pass out.  Called to the parking lot and she was awake,pale,talking and sitting on the ground. Assisted to a wheelchair and brought back to the office.
Age: 75.0
Sex: F
Vaccine: VARZOS
Symptoms: Immediate post-injection reaction, Injection site erythema, Injection site inflammation, Injection site pruritus, Injection site rash
Clinical narrative: Red blotch ~ 2 inches in length and 1 inch in width down back of arm at injection site.  Patient said that is appeared slightly red shortly after injection, however today (7/27/2009) 6 days after, the site is inflammed and brighter in color.  Patient also stated that it has started to itch today (7/27/2009)
Age: 4.0
Sex: F
Vaccine: DTAP, IPV, MMR, VARCEL
Symptoms: Cyanosis, Feeling abnormal, Immediate post-injection reaction, Musculoskeletal stiffness, Syncope
Clinical narrative: upper extremities became stiff immediately after receiving DTaP/IPV/MMR II/VARIVAX fainted within 2 mins of first injection lips cyanotic. No drooling, twitching, given O2 x 20. 2:50 pm able to sit up but dazed/post ictal 3:30 pm - ok able to suck on popsicle.
Age: 5.0
Sex: M
Vaccine: DTAPIPV, MMR, VARCEL
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: Left thigh red and raised
Age: 16.0
Sex: F
Vaccine: HPV4, VARCEL
Symptoms: Dizziness, Erythema, Presyncope, Pyrexia, Swelling
Clinical narrative: VARICELLA - redness / swelling 7/10/09 GARDASIL -  Dizziness, light headed - almost fainted, fever X 48 - 72 hours
Age: 11.0
Sex: F
Vaccine: HEPA, MNQ, TDAP, VARCEL
Symptoms: Erythema, Pruritus, Urticaria
Clinical narrative: Localized hives, erythema, itchy within 5 min of injection.  BENADRYL 25 mg IM given - symptoms relieved within 15 min of BENADRYL.
Age: 1.3
Sex: F
Vaccine: DTAP, MMR, PNC, VARCEL
Symptoms: Full blood count, Injection site erythema, Injection site urticaria, Injection site warmth
Clinical narrative: Patient got MMR #1, VARICELLA #1, DTAP#4 , PRENVAR#4 + HIB#4. after 10 minutes, mom noted redness ~ the night of the MMR, a few minutes later, became a hive with 1 inch diameter redness stated on the Varicella site too, hot mild.
Age: 0.2
Sex: F
Vaccine: DTAP, RV5
Symptoms: Hypophagia, Injection site erythema, Injection site rash, Injection site warmth, Somnolence
Clinical narrative: 48 hrs after DTaP Imm. infant sleepy for 24 hrs with taking only few oz. of formula - Afebrile developed erythematous rash on thigh surrounding shot - warm to touch but leg not painful.
Age: 12.0
Sex: F
Vaccine: MNQ
Symptoms: Back pain, Headache, Injection site erythema, Injection site induration, Injection site warmth
Clinical narrative: Site warm, firm erythematous mild ascending weakness to legs & arms neck pain back pain nausea HA.
Age: 12.0
Sex: F
Vaccine: MNQ
Symptoms: Muscular weakness, Nausea, Neck pain
Clinical narrative: Site warm, firm erythematous mild ascending weakness to legs & arms neck pain back pain nausea HA.
Age: 19.0
Sex: F
Vaccine: HEP
Symptoms: Erythema, Pruritus, Rash, Rash macular
Clinical narrative: HEP B injection given on Monday. Wednesday morning noted rash to arms. Late evening it spread to legs. Rash is red blotchy and itches. Rash on arms ongoing per Pt.
Age: 0.3
Sex: F
Vaccine: DTAP, PNC, RV5
Symptoms: Lymphadenopathy, Ultrasound scan abnormal
Clinical narrative: Pt developed enlarged left inguinal node on same side that vaccine was given.
Age: 66.0
Sex: F
Vaccine: PPV
Symptoms: Erythema, Pain
Clinical narrative: Redness - Soreness proximal to injection site.
Age: 4.0
Sex: M
Vaccine: DTAP, IPV, VARCEL
Symptoms: Injection site erythema, Injection site oedema, Injection site warmth, Pyrexia, Urticaria
Clinical narrative: erythema, edema, warmth entire right upper arm urticaria over entire body.  No breathing distress and fever 100.4.
Age: 2.0
Sex: F
Vaccine: HIBV
Symptoms: Injection site cellulitis
Clinical narrative: Cellulitis left thigh
Age: 77.0
Sex: F
Vaccine: FLU3
Symptoms: Dizziness, Headache, Injection site erythema, Injection site swelling, Oedema peripheral
Clinical narrative: This case was reported by a physician and described the occurrence of swelling injection site in a 77-year-old female subject who was vaccinated with (FLULAVAL, GlaxoSmithKline). Concurrent medications included (ZOCOR), (COUMADIN), (DIGITEK), (ACTONEL), (CLARITIN), (PRILOSEC) and Potassium salt (Potassium). On 23 June 2009, the subject received a dose of FLULAVAL (.1 cc, unknown, left arm). On 23 June 2008, less than one day after vaccination after vaccination with FLULAVAL, the subject experienced swelling injection site, arm pain, headache, dizziness, injection site redness, swelling arm and wrong vaccine administered. At the time of reporting the events were unresolved. The physician considered the events were probably related to vaccination with FLULAVAL. The subject was administered the FLULAVAL vaccine in error and the home health nurse administered the vaccine in the subject's arm. The subject returned to the physician's office today complaining of headache and dizziness as well as a swollen, sore arm and the arm is red at the injection site. Physician had no detailed information regarding lot number or expiration date information. Physician does not believe that the subject has had a similar reaction to previous flu shots in the past. 10/07/2009 Follow up received from the reporting physician 27 July 2009: The subject received FLULAVAL intradermally instead of intramuscularly (intramuscular formulation administered by other route). She was supposed to get PPD TB test. The events improved on 30 June 2009. The physician considered the events could have been associated with erroneous administration.
Age: 77.0
Sex: F
Vaccine: FLU3
Symptoms: Pain in extremity, Wrong drug administered
Clinical narrative: This case was reported by a physician and described the occurrence of swelling injection site in a 77-year-old female subject who was vaccinated with (FLULAVAL, GlaxoSmithKline). Concurrent medications included (ZOCOR), (COUMADIN), (DIGITEK), (ACTONEL), (CLARITIN), (PRILOSEC) and Potassium salt (Potassium). On 23 June 2009, the subject received a dose of FLULAVAL (.1 cc, unknown, left arm). On 23 June 2008, less than one day after vaccination after vaccination with FLULAVAL, the subject experienced swelling injection site, arm pain, headache, dizziness, injection site redness, swelling arm and wrong vaccine administered. At the time of reporting the events were unresolved. The physician considered the events were probably related to vaccination with FLULAVAL. The subject was administered the FLULAVAL vaccine in error and the home health nurse administered the vaccine in the subject's arm. The subject returned to the physician's office today complaining of headache and dizziness as well as a swollen, sore arm and the arm is red at the injection site. Physician had no detailed information regarding lot number or expiration date information. Physician does not believe that the subject has had a similar reaction to previous flu shots in the past. 10/07/2009 Follow up received from the reporting physician 27 July 2009: The subject received FLULAVAL intradermally instead of intramuscularly (intramuscular formulation administered by other route). She was supposed to get PPD TB test. The events improved on 30 June 2009. The physician considered the events could have been associated with erroneous administration.
Age: 26.0
Sex: F
Vaccine: SMALL, SMALL
Symptoms: Abortion induced, Drug exposure during pregnancy
Clinical narrative: This case was received on 07 May via a QScan search on the VAERS database, under reference number 339719.  A 26 year old female patient received ACAM2000 (lot number VV04-003A).  The patient was vaccinated during pregnancy.  The outcome of the pregnancy was reported as voluntary interruption at approximately 11 weeks 2 days.  The onset date reported was 19 days after vaccination.  It is not obvious by the report what this date refers to.  No additional information was reported.  List of Documents held by Sender:  None
Age: 21.0
Sex: M
Vaccine: SMALL, SMALL, SMALL
Symptoms: Rash
Clinical narrative: A 21 year old male patient received ACAM2000, Sanofi Pasteur Biologics Co., lot number W04-003A) on 16 December 2008. The patient is reported to have an erythematous, maculopapular rash which is also mildly pruritic. The rash is located in the antecubital fossae bilaterally, the dorsum of the hand and on the proximal legs bilaterally. No additional information was reported. List of documents held by sender none.
Age: 21.0
Sex: M
Vaccine: SMALL, SMALL, SMALL
Symptoms: Pruritus, Rash erythematous, Rash maculo-papular
Clinical narrative: A 21 year old male patient received ACAM2000, Sanofi Pasteur Biologics Co., lot number W04-003A) on 16 December 2008. The patient is reported to have an erythematous, maculopapular rash which is also mildly pruritic. The rash is located in the antecubital fossae bilaterally, the dorsum of the hand and on the proximal legs bilaterally. No additional information was reported. List of documents held by sender none.
Age: 21.0
Sex: M
Vaccine: SMALL, SMALL, SMALL
Symptoms: Rash erythematous, Rash maculo-papular, Rash pruritic
Clinical narrative: A 21 year old male patient received ACAM2000, Sanofi Pasteur Biologics Co., lot number W04-003A) on 16 December 2008. The patient is reported to have an erythematous, maculopapular rash which is also mildly pruritic. The rash is located in the antecubital fossae bilaterally, the dorsum of the hand and on the proximal legs bilaterally. No additional information was reported. List of documents held by sender none.
Age: 26.0
Sex: M
Vaccine: ANTH, SMALL, ANTH, SMALL
Symptoms: Cellulitis, Rash pustular
Clinical narrative: This case was received on 14 April 2009 via a QScan search on the VAERS database, under reference number 337138. A 26 year old male patient received ACAM2000 (Sanofi Pasteur Biologics Co., lot number reported as "003A") and BIOTHRAX (Emergent Biosolutions) on 08 December 2008. Ten days after vaccination, the patient developed a satellite pustule near the vaccination site. The area around the site appeared to have a generalized cellulitis. The patient was referred to the Emergency Room, received treatment (not specified) and was released. The patient was given BACTROBAN 20% to administer to a questionable pustule located on the side of his nose. The report states no other medications or treatments were given. List of Documents held by Sender: None.
Age: 26.0
Sex: M
Vaccine: ANTH, SMALL, ANTH, SMALL
Symptoms: Injection site cellulitis, Injection site pustule, Rash pustular
Clinical narrative: This case was received on 14 April 2009 via a QScan search on the VAERS database, under reference number 337138. A 26 year old male patient received ACAM2000 (Sanofi Pasteur Biologics Co., lot number reported as "003A") and BIOTHRAX (Emergent Biosolutions) on 08 December 2008. Ten days after vaccination, the patient developed a satellite pustule near the vaccination site. The area around the site appeared to have a generalized cellulitis. The patient was referred to the Emergency Room, received treatment (not specified) and was released. The patient was given BACTROBAN 20% to administer to a questionable pustule located on the side of his nose. The report states no other medications or treatments were given. List of Documents held by Sender: None.
Age: 22.0
Sex: F
Vaccine: SMALL, SMALL
Symptoms: Nodule, Skin lesion
Clinical narrative: This case was received on 14 April 2009 via a Q Scan on the VARES database, under reference 337778. A 22-year-old female patient received ACAM2000, Sanofi Pasteur Biologics Co., lot number W04003A on 18 April 2008. On 07 January 2009 (8 months post smallpox vaccination) the patient complained of having a post-smallpox reaction of a pimple and nodule formation around the vaccination site. No additional information, including outcome was reported.
Age: 22.0
Sex: F
Vaccine: SMALL, SMALL
Symptoms: Injection site nodule, Injection site papule
Clinical narrative: This case was received on 14 April 2009 via a Q Scan on the VARES database, under reference 337778. A 22-year-old female patient received ACAM2000, Sanofi Pasteur Biologics Co., lot number W04003A on 18 April 2008. On 07 January 2009 (8 months post smallpox vaccination) the patient complained of having a post-smallpox reaction of a pimple and nodule formation around the vaccination site. No additional information, including outcome was reported.
Age: 34.0
Sex: M
Vaccine: SMALL, ANTH, SMALL, TD, TYP, SMALL
Symptoms: Computerised tomogram, Erythema, Eye oedema, Metamorphopsia, Slit-lamp examination
Clinical narrative: This case was received on 14 April 2009 via a QScan search on the VAERS database, under reference number 338419. A 34 year-old male patient received smallpox vaccine (manufacturer and lot number not reported) on 15 December 2008. Eight days after vaccination, the patient reported erythema, edema of the eye and distorted vision. The events are reported as a possible auto-inoculation. The patient was hospitalized (dates not reported). Tests performed include a CT of the head, slit lamp evaluations and fluorosein staining. Results were not included in report. The patient recovered. NOTE: Although the manufacturer was reported as unknown in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination. List of Documents held by sender: None.
Age: 34.0
Sex: M
Vaccine: SMALL, ANTH, SMALL, TD, TYP, SMALL
Symptoms: Conjunctival oedema, Corneal disorder, Corneal lesion, Eyelid oedema, Purulence
Clinical narrative: This case was received on 14 April 2009 via a QScan search on the VAERS database, under reference number 338419. A 34 year-old male patient received smallpox vaccine (manufacturer and lot number not reported) on 15 December 2008. Eight days after vaccination, the patient reported erythema, edema of the eye and distorted vision. The events are reported as a possible auto-inoculation. The patient was hospitalized (dates not reported). Tests performed include a CT of the head, slit lamp evaluations and fluorosein staining. Results were not included in report. The patient recovered. NOTE: Although the manufacturer was reported as unknown in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination. List of Documents held by sender: None.
Age: 34.0
Sex: M
Vaccine: SMALL, ANTH, SMALL, TD, TYP, SMALL
Symptoms: Secondary transmission, Skin lesion, Vaccinia, Viral infection
Clinical narrative: This case was received on 14 April 2009 via a QScan search on the VAERS database, under reference number 338419. A 34 year-old male patient received smallpox vaccine (manufacturer and lot number not reported) on 15 December 2008. Eight days after vaccination, the patient reported erythema, edema of the eye and distorted vision. The events are reported as a possible auto-inoculation. The patient was hospitalized (dates not reported). Tests performed include a CT of the head, slit lamp evaluations and fluorosein staining. Results were not included in report. The patient recovered. NOTE: Although the manufacturer was reported as unknown in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination. List of Documents held by sender: None.
Age: 34.0
Sex: M
Vaccine: SMALL, ANTH, SMALL, TD, TYP, SMALL
Symptoms: Erythema, Eye oedema, Metamorphopsia, Scan brain
Clinical narrative: This case was received on 14 April 2009 via a QScan search on the VAERS database, under reference number 338419. A 34 year-old male patient received smallpox vaccine (manufacturer and lot number not reported) on 15 December 2008. Eight days after vaccination, the patient reported erythema, edema of the eye and distorted vision. The events are reported as a possible auto-inoculation. The patient was hospitalized (dates not reported). Tests performed include a CT of the head, slit lamp evaluations and fluorosein staining. Results were not included in report. The patient recovered. NOTE: Although the manufacturer was reported as unknown in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination. List of Documents held by sender: None.
Age: 26.0
Sex: M
Vaccine: ANTH, SMALL, ANTH, SMALL
Symptoms: Asthenia, Chest pain, Chills
Clinical narrative: This case was received on 14 April 2009 via a QScan search on the VAERS database, under reference number 338601. The patient is a 26 year-old male who received ACAM2000 (Sanofi Pasteur Biologics Co., lot number reported as W04003A) and BIOTHRAX (Emergent Biosolutions, lot number reported as FAV149) on 20 January 2009. One day after vaccination, the patient reported chills and weakness. Three days after vaccination, the patient reported chest pains and was told he had gas when seen at an Aid Station. The chest pain continued for an additional three days and he was referred to the Emergency Room. He was diagnosed with pleurisy and received medicine. Information on the type of medicine received was not reported. The symptoms of chest pain and weakness were reported to be continuing as of nine days after vaccination, however, some improvement was noted. Emergency medical records received on 9 February 2009 by the reporter included a final diagnosis of pleuritic chest pain, and urinary tract infection. Symptoms noted in the record include: chest pain, dyspnea on exertion, chills and nonproductive cough x 3 days. The record notes that the patient was treated with medication (not specified) and sent home. Blood chemistry, CPK, CKMB, troponin, chest X-ray and EKG were reported within normal limits. Blood WBC was reported as 3.9. List of document held by sender: none.
Age: 26.0
Sex: M
Vaccine: ANTH, SMALL, ANTH, SMALL
Symptoms: Asthenia, Blood creatine phosphokinase MB normal, Blood creatine phosphokinase normal, Chest X-ray normal, Chest pain
Clinical narrative: This case was received on 14 April 2009 via a QScan search on the VAERS database, under reference number 338601. The patient is a 26 year-old male who received ACAM2000 (Sanofi Pasteur Biologics Co., lot number reported as W04003A) and BIOTHRAX (Emergent Biosolutions, lot number reported as FAV149) on 20 January 2009. One day after vaccination, the patient reported chills and weakness. Three days after vaccination, the patient reported chest pains and was told he had gas when seen at an Aid Station. The chest pain continued for an additional three days and he was referred to the Emergency Room. He was diagnosed with pleurisy and received medicine. Information on the type of medicine received was not reported. The symptoms of chest pain and weakness were reported to be continuing as of nine days after vaccination, however, some improvement was noted. Emergency medical records received on 9 February 2009 by the reporter included a final diagnosis of pleuritic chest pain, and urinary tract infection. Symptoms noted in the record include: chest pain, dyspnea on exertion, chills and nonproductive cough x 3 days. The record notes that the patient was treated with medication (not specified) and sent home. Blood chemistry, CPK, CKMB, troponin, chest X-ray and EKG were reported within normal limits. Blood WBC was reported as 3.9. List of document held by sender: none.
Age: 26.0
Sex: M
Vaccine: ANTH, SMALL, ANTH, SMALL
Symptoms: Chills, Cough, Dyspnoea exertional, Electrocardiogram normal, Laboratory test normal
Clinical narrative: This case was received on 14 April 2009 via a QScan search on the VAERS database, under reference number 338601. The patient is a 26 year-old male who received ACAM2000 (Sanofi Pasteur Biologics Co., lot number reported as W04003A) and BIOTHRAX (Emergent Biosolutions, lot number reported as FAV149) on 20 January 2009. One day after vaccination, the patient reported chills and weakness. Three days after vaccination, the patient reported chest pains and was told he had gas when seen at an Aid Station. The chest pain continued for an additional three days and he was referred to the Emergency Room. He was diagnosed with pleurisy and received medicine. Information on the type of medicine received was not reported. The symptoms of chest pain and weakness were reported to be continuing as of nine days after vaccination, however, some improvement was noted. Emergency medical records received on 9 February 2009 by the reporter included a final diagnosis of pleuritic chest pain, and urinary tract infection. Symptoms noted in the record include: chest pain, dyspnea on exertion, chills and nonproductive cough x 3 days. The record notes that the patient was treated with medication (not specified) and sent home. Blood chemistry, CPK, CKMB, troponin, chest X-ray and EKG were reported within normal limits. Blood WBC was reported as 3.9. List of document held by sender: none.
Age: 26.0
Sex: M
Vaccine: ANTH, SMALL, ANTH, SMALL
Symptoms: Pleuritic pain, Troponin, Urinary tract infection, White blood cell count decreased
Clinical narrative: This case was received on 14 April 2009 via a QScan search on the VAERS database, under reference number 338601. The patient is a 26 year-old male who received ACAM2000 (Sanofi Pasteur Biologics Co., lot number reported as W04003A) and BIOTHRAX (Emergent Biosolutions, lot number reported as FAV149) on 20 January 2009. One day after vaccination, the patient reported chills and weakness. Three days after vaccination, the patient reported chest pains and was told he had gas when seen at an Aid Station. The chest pain continued for an additional three days and he was referred to the Emergency Room. He was diagnosed with pleurisy and received medicine. Information on the type of medicine received was not reported. The symptoms of chest pain and weakness were reported to be continuing as of nine days after vaccination, however, some improvement was noted. Emergency medical records received on 9 February 2009 by the reporter included a final diagnosis of pleuritic chest pain, and urinary tract infection. Symptoms noted in the record include: chest pain, dyspnea on exertion, chills and nonproductive cough x 3 days. The record notes that the patient was treated with medication (not specified) and sent home. Blood chemistry, CPK, CKMB, troponin, chest X-ray and EKG were reported within normal limits. Blood WBC was reported as 3.9. List of document held by sender: none.